Drug Profile
Fulvestrant - Eagle Pharmaceuticals
Alternative Names: EA 114; EGL-5385-C-1701; Fulvestrant for injectable suspension - Eagle PharmaceuticalsLatest Information Update: 31 Aug 2023
Price :
$50
*
At a glance
- Originator Eagle Pharmaceuticals
- Class Antineoplastics; Estradiol congeners; Estrenes; Fluorinated hydrocarbons; Small molecules; Sulfoxides
- Mechanism of Action Estrogen receptor antagonists; Selective estrogen receptor degraders
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Breast cancer